Strides Arcolab receives ANDA approval
New Delhi, Apr 24 (UNI) Bangalore-based Strides Arcolab Ltd today said it has received two Abbreviated New Drug Application (ANDA) approvals for Ondansetron Injection USP, two mg/ml in 20 ml and two ml vials.
The product is licensed to Akorn-Strides, LLC, which is a joint venture of Akorn and Stride Arcolab Ltd.
''These approvals reflect yet another significant milestone for the Akorn-Strides partnership which now has approvals for five sterile injectable products and plans for commercialisation are underway,'' Strides Arcolab Vice Chairman and Group CEO Arun Kumar said in a statement.
UNI SR SG PM1655
More From
-
Gold Silver Rate Today, 9 March 2026: City-Wise Prices, MCX Gold and Silver Ease Slightly After Rally -
Chinese Spy Ship Liaowang-1 Spotted Near Oman: Why Its Presence Near Oman Is Concerning For US Military -
Pune Gold Rate Today: Check Gold Prices For 18K, 22K, 24K in Pune -
Bangalore Gold Silver Rate Today, March 9, 2026: Gold and Silver Prices Fall as US Dollar Strengthens -
Who Is Nishant Kumar: Education, Personal Life and Possible Political Role -
Ind Vs NZ T20 World Cup Phalodi Satta Bazar Prediction: Know Who Will Win In India vs New Zealand Final -
Vijay-NDA Alliance On Cards? Pawan Kalyan Reportedly Reaches Out to TVK Chief -
Who Was Mojtaba Khamenei’s Wife Zahra Haddad-Adel and What Do We Know About Her? -
Trisha Hits Back at Parthiban: 'Crude Words Say More About the Speaker' -
India vs New Zealand T20 World Cup 2026 Final: Five Positive Signs Favouring India Before Title Clash -
IND vs NZ Final Live: When and Where to Watch India vs New Zealand T20 World Cup 2026 Title Clash -
Ind vs NZ T20 World Cup 2026: New Zealand Needs 256 Runs To Beat India And Win The World Cup
Click it and Unblock the Notifications
Sign in with Google